Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
Liver Physiology01:30

Liver Physiology

457
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
457
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

490
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
490
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

71
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
71

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Profile of patients attending private vestibular physiotherapy clinics in Spain: A cross-sectional study.

Physiotherapy·2026
Same author

Effectiveness of cardiac Holter monitoring for more than four weeks for the detection of occult atrial fibrillation in embolic stroke of undetermined source.

Medicina clinica·2026
Same author

Immediate allergic reactions to penicillins: unanswered questions.

Current opinion in allergy and clinical immunology·2026
Same author

Blood multiomics reveal a dysregulated lipid mediator-mitochondrial network associated with the outcome of advanced cirrhosis.

Nature communications·2026
Same author

Antibiotic Allergy Labels in Hospitalized Patients: Results of a Multicenter Cross-Sectional Study.

Journal of investigational allergology & clinical immunology·2026
Same author

Calling for Diversity: Improving Transfusion Safety Through High-Throughput Blood Group Microarray Genotyping.

Genomics, proteomics & bioinformatics·2026

相关实验视频

Updated: Jun 15, 2025

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

10.1K

急性肝衰竭:一个实际的更新.

Javier Fernández1,2, Octavi Bassegoda1, David Toapanta1

  • 1Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Spain.

JHEP reports : innovation in hepatology
|August 22, 2024
PubMed
概括
此摘要是机器生成的。

急性肝衰竭 (ALF) 管理通过更好的重症监护和早期干预改善了生存率. 进展侧重于预防内高血压等并发症,并确定最佳肝移植候选人.

关键词:
内高血压是什么意思支持肝脏 支持肝脏肝移植 肝移植 肝移植死亡率 死亡率 死亡率预后 预后 预后

更多相关视频

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

11.3K
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

12.7K

相关实验视频

Last Updated: Jun 15, 2025

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

10.1K
Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

11.3K
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

12.7K

科学领域:

  • 肝病学 肝病学是一种肝病学.
  • 关键护理医学 关键护理医学
  • 移植手术 移植手术

背景情况:

  • 急性肝衰竭 (ALF) 是一种罕见的,严重的疾病,有多种原因和复杂的病理生理学.
  • 有效的管理需要密集护理,器官支持,并且经常及时进行肝移植.
  • 诸如内高血压和败血症等并发症显著影响患者的结果.

研究的目的:

  • 提供关于急性肝衰竭管理的临床更新.
  • 将最近在ALF的诊断,治疗和预后方面的进展纳入其中.
  • 要突出在临床重症监护和器官支持ALF患者的不断发展的策略.

主要方法:

  • 审查目前的文学和临床实践在急性肝衰竭管理.
  • 对重症监护,器官支持和肝移植方面的进展进行分析.
  • 对诊断和预后工具的评估,包括非侵入性内压力监测.

主要成果:

  • 由于医疗治疗的进步,ALF的生存率有所改善.
  • 现在,对于大脑内压力监测,非侵入性技术是首选的.
  • 当前的预后模型准确地识别了非移植候选人,但不是徒劳的移植病例.

结论:

  • 快速识别ALF病因和早期治疗对于改善预后至关重要.
  • 治疗性血交换和早期置换疗法是已知的治疗方法.
  • 对新的预后标志物进行进一步的研究是必要的,以指导肝移植决策.